These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8018390)

  • 21. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
    Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
    Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tat is required for efficient HIV-1 reverse transcription.
    Harrich D; Ulich C; García-Martínez LF; Gaynor RB
    EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.
    Ott M; Emiliani S; Van Lint C; Herbein G; Lovett J; Chirmule N; McCloskey T; Pahwa S; Verdin E
    Science; 1997 Mar; 275(5305):1481-5. PubMed ID: 9045614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection.
    Gibellini D; Caputo A; Celeghini C; Bassini A; La Placa M; Capitani S; Zauli G
    Br J Haematol; 1995 Jan; 89(1):24-33. PubMed ID: 7530479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC; Lin JK; Chen SS
    Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
    Raymond AD; Hasham M; Tsygankov AY; Henderson EE
    Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
    Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
    Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells.
    Wrenger S; Reinhold D; Hoffmann T; Kraft M; Frank R; Faust J; Neubert K; Ansorge S
    FEBS Lett; 1996 Apr; 383(3):145-9. PubMed ID: 8925885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line.
    Emiliani S; Fischle W; Ott M; Van Lint C; Amella CA; Verdin E
    J Virol; 1998 Feb; 72(2):1666-70. PubMed ID: 9445075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells.
    Löhr M; Kibler KV; Zachary I; Jeang KT; Selwood DL
    Biochem Biophys Res Commun; 2003 Jan; 300(2):609-13. PubMed ID: 12504126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Tat antagonist inhibits HIV-1 induction in naturally infected and experimentally infected T cells.
    Potash MJ; Bentsman G; McKinley G; Volsky DJ
    Biochem Biophys Res Commun; 1992 Nov; 189(1):250-6. PubMed ID: 1449479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric quantification of HIV-1 Tat protein in tat-transfected Jurkat T cell lines.
    Gibellini D; Re MC; Panaya R; Venturi E; Milani D; La Placa M; Zauli G
    J Immunol Methods; 1998 Dec; 221(1-2):107-17. PubMed ID: 9894902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines.
    Sharma V; Knobloch TJ; Benjamin D
    Biochem Biophys Res Commun; 1995 Mar; 208(2):704-13. PubMed ID: 7695626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers.
    Arrigo SJ; Huffman K
    J Virol; 1995 Oct; 69(10):5988-94. PubMed ID: 7666503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a biological assay system for human retroviral protease activity.
    Yoshida A; Piroozmand A; Sakurai A; Fujita M; Uchiyama T; Kimura T; Hayashi Y; Kiso Y; Adachi A
    Microbes Infect; 2005 May; 7(5-6):820-4. PubMed ID: 15893491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased ability of HIV-1 tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells.
    Wu MX; Schlossman SF
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13832-7. PubMed ID: 9391113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.